Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Aug 21;18(31):4145-9.
doi: 10.3748/wjg.v18.i31.4145.

A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma

Roberto Hernandez-Alejandro  1 , Kris P Croome, Martin Drage, Nathalie Sela, Jeremy Parfitt, Natasha Chandok, Paul Marotta, Cheryl Dale, William Wall, Douglas Quan
Affiliations
Comparative Study

A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma

Roberto Hernandez-Alejandro et al. World J Gastroenterol. .

Abstract

Aim: To compare the clinical outcome and pathologic features of non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) and hepatitic C virus (HCV) patients with HCC (another group in which HCC is commonly seen) undergoing liver transplantation.

Methods: Patients transplanted for HCV and NASH at our institution from January 2000 to April 2011 were analyzed. All explanted liver histology and pre-transplant liver biopsies were examined by two specialist liver histopathologists. Patient demographics, disease free survival, explant liver characteristics and HCC features (tumour number, cumulative tumour size, vascular invasion and differentiation) were compared between HCV and NASH liver transplant recipients.

Results: A total of 102 patients with NASH and 283 patients with HCV were transplanted. The incidence of HCC in NASH transplant recipients was 16.7% (17/102). The incidence of HCC in HCV transplant recipients was 22.6% (64/283). Patients with NASH-HCC were statistically older than HCV-HCC patients (P < 0.001). A significantly higher proportion of HCV-HCC patients had vascular invasion (23.4% vs 6.4%, P = 0.002) and poorly differentiated HCC (4.7% vs 0%, P < 0.001) compared to the NASH-HCC group. A trend of poorer recurrence free survival at 5 years was seen in HCV-HCC patients compared to NASH-HCC who underwent a Liver transplantation (P = 0.11).

Conclusion: Patients transplanted for NASH-HCC appear to have less aggressive tumour features compared to those with HCV-HCC, which likely in part accounts for their improved recurrence free survival.

Keywords: Comparison; Hepatitis C virus; Hepatocellular carcinoma; Liver transplant; Non-alcoholic steatohepatitis; Poorly differentiated; Recurrence; Survival; Vascular invasion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagnosis in patients undergoing liver transplantation. HCC: Hepatocellular carcinoma; HCV: Hepatitic C virus; NASH: Non-alcoholic steatohepatitis.
Figure 2
Figure 2
Recurrence free survival in non-alcoholic steatohepatitis-hepatocellular carcinoma vs hepatitis c virus-hepatocellular carcinoma groups. HCC: Hepatocellular carcinoma; HCV: Hepatitic C virus; NASH: Non-alcoholic steatohepatitis.
See this image and copyright information in PMC

References

    1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555. - PubMed
    1. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–649. - PubMed
    1. Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history? Am J Gastroenterol. 2003;98:1915–1917. - PubMed
    1. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005;42:132–138. - PubMed
    1. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042–2047. - PubMed

Publication types

MeSH terms